Back to top

Top Ranked Momentum Stocks to Buy for August 31st

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 31st:

Rexahn Pharmaceuticals, Inc. (RNN - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 9.5% over the last 60 days.

Rexahn Pharmaceuticals' shares gained 13.9% over the last one month higher than the S&P 500’s increase of 3%. The company possesses a Momentum Score of A.

The E.W. Scripps Company (SSP - Free Report) : This media enterprise has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 15.3% over the last 60 days.

E.W. Scripps' shares gained 11.7% over the last one month. The company possesses a Momentum Score of A.

Sesen Bio, Inc. (SESN - Free Report) : This late-stage clinical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 18.8% over the last 60 days.

Sesen Bio's shares gained 17.1% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

5 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.

Click to see them right now >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


E.W. Scripps Company (The) (SSP) - free report >>

Eleven Biotherapeutics, Inc. (SESN) - free report >>

Rexahn Pharmaceuticals, Inc. (RNN) - free report >>

More from Zacks Zacks #1 Rank Additions

You May Like